Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom
D'Arcy, P.F.
Journal de Pharmacie de Belgique 54(2): 44-47
1999
ISSN/ISBN: 0047-2166 PMID: 10380410 Document Number: 506176
Document emailed within 1 workday
Related Documents
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Aimono, Y.; Kamoshida, T.; Sakamoto, R.; Nemoto, M.; Saito, Y.; Aoyama, Y.; Maruyama, T. 2015: Initial Evaluation of the Efficacy and Safety of Tablets Containing Trifluridine and Tipiracil Hydrochloride--Safety Measures Devised by a Multidisciplinary Team Including a Pharmaceutical Outpatient Clinic Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(7): 817-820
Alostad, A.H.; Steinke, D.T.; Schafheutle, E.I. 2018: International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain Pharmaceutical Medicine 32(1): 39-49
Sato, T.; Kariya, K. 1996: Theoretical prediction of safety and efficacy of drugs--safety Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 108(3): 183-185
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432
Roeser, H.P.; Rohan, A.P. 1990: Post-marketing surveillance of drugs. The spontaneous reporting scheme: role of the Adverse Drug Reactions Advisory Committee Medical Journal of Australia 153(11-12): 720-726
Richard, B.W.; Lasagna, L. 1987: Drug regulation in the United States and the United Kingdom: the Depo-Provera story Annals of Internal Medicine 106(6): 886-891
2012: Naming drug substances at the national level: mainly in the United Kingdom and the United States Prescrire International 21(132): 279
Stoskopf, M.K. 1995: AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the Aquaculture and Seafood Safety Advisory Committee (ASSAC) Journal of the American Veterinary Medical Association 207(7): 889-9; discussion 890-4
Liccardi, G.; Salzillo, A.; Piccolo, A.; Senna, G.; Piscitelli, E.; D'Amato, M.; D'Amato, G. 2005: Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs European Annals of Allergy and Clinical Immunology 37(2): 50-53
Krajnović, P.; Ferić, V. 1974: Studies on drug safety in gynecology. on the passage of drugs into maternal milk Arzneimittel-Forschung 24(7): 1061-1063
De Boeck, E.; Mortier, A.V.; Jacxsens, L.; Dequidt, L.; Vlerick, P. 2017: Towards an extended food safety culture model: Studying the moderating role of burnout and jobstress, the mediating role of food safety knowledge and motivation in the relation between food safety climate and food safety behavior Trends in Food Science and Technology 62: 202-214
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
McGillion, F.B. 1979: A consideration of the guidelines for investigating potential new drugs in humans in the United Kingdom Methods and Findings in Experimental and Clinical Pharmacology 1(1): 45-50
McQuade, J. 1976: The use and abuse of a safety committee Dimensions in Health Service 53(2): 14-5 17
Rosdahl, N. 2000: Food safety within the EU; the document of the EF committee Ugeskrift for Laeger 162(14): 2056-2057
Jennum, P.; Kristensen, M.B. 1985: Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983 Ugeskrift for Laeger 147(32): 2539-2541
Millar, F.A.; Mackenzie, A.; Hutchison, G.; Bannister, J. 1996: Hemostasis-altering drugs and central neural block. A survey of anesthetic practice in Scotland and the United Kingdom Regional Anesthesia 21(6): 529-533
Miyamoto, T. 2013: History of discussions of the Committee for Medical Safety Review Nihon Geka Gakkai Zasshi 114(2): 80-84